- FDA Law Blog had a post Thursday about "The Dog Ate My Homework Act," which would give a reprieve to companies that miss the deadline for filing a patent term extension request.
- Pharmalot had this post Wednesday, reporting that Congress has delayed the FDA bill until September.
- Patently-O reported Wednesday on the Federal Circuit’s decision on Washington, D.C.’s drug price law. PhRMA made a press release on the decision. The Washington Post published this article on the case.
- Tuesday, Wyeth announced a deal with Teva and Sun concerning generic Protonix. Today, Teva announced that FDA approved its ANDA for Protonix.
- Investor’s Business Daily had an interesting article last week, "RNAi Stirs Excitement in Big Pharma."
- The Patent Prospector had a neat post last week, "Dealing with KSR."
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 
Leave a comment